• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Oncology

Latest News

AJMC
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage

April 4th 2025

This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.

Woman with keloid on shoulder | Image credit: weerajata – stock.adobe.com
Deep Learning Tool Differentiates Keloids From Malignant Lesions Without Dermoscopy

April 2nd 2025

Round FDA approval stamp in blue ink | Image Credit: © Surendra - stock.adobe.com
FDA Approves Durvalumab Combo for Muscle-Invasive Bladder Cancer

March 31st 2025

FDA Approved. | Image Credit: wladimir1804 - stock.adobe.com
FDA Approves Cabozantinib for Advanced Pancreatic Neuroendocrine Tumors

March 26th 2025

Doctor showing patient x-ray of lung cancer. | Image credit: Nattakorn – stock.adobe.com
3 DDR Phenotypes May Predict Chemotherapy Response in SCLC

March 25th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences
AJMC®
All rights reserved.